Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland.

Jean-Pierre Gutzwiller, Jean-Pierre Richterich, Zeno Stanga, Urs E Nydegger, Lorenz Risch, Martin Risch

Journal: BMC geriatrics 2019;18(1):115

PMID: 29764380

Abstract

BACKGROUND

Osteoporosis is an important morbidity factor for ageing populations in developed countries. However, compared to the amount of information available on diabetes and cardiovascular disease, little is known about the direct impact of osteoporosis on general mortality in older age.

METHODS

We obtained data from a prospective population-based cohort of pensioners from the SENIORLAB study who were subjectively healthy. The inclusion criteria were an age of at least 60 years and Swiss residence. We assessed and analysed clinical measures, voluntary reports, and laboratory values.

RESULTS

In total, 1467 subjects were included in the cohort. The mean follow-up time was 3.68 years (95% confidence interval, 3.64-3.71). The ages of the included participants ranged from 60 to 99 years. At follow-up, there were 1401 survivors, and 66 participants had died. According to the multivariate analysis (Cox regression), osteoporosis was the most important risk factor for all-cause mortality (hazard ratio, 4.46; 95% confidence interval, 1.82-10.91), followed by diabetes (hazard ratio, 2.17; 95% confidence interval, 1.04-4.52) and hypertension (hazard ratio, 1.81; 95% confidence interval, 1.09-3.03).

CONCLUSIONS

Osteoporosis is a major risk factor for all-cause mortality in a subjectively healthy senior population, followed by type 2 diabetes mellitus and hypertension. Osteoporosis should be more actively diagnosed in healthy pensioners before they develop osteoporosis-associated health incidents.

TRIAL REGISTRATION

The present study was registered in the International Standard Randomized Controlled Trial Number registry: ISRCTN53778569 .

Address: Magendarm Thalwil AG, Zürcherstrasse 61, CH-8800, Thalwil, Switzerland. [email protected].; University of Basel, Klingelbergstrasse 61, 4056, Basel, Switzerland. [email protected].; Magendarm Thalwil AG, Zürcherstrasse 61, CH-8800, Thalwil, Switzerland.; Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital and University of Bern, Bern, Switzerland.; Department of General Internal Medicine, Bern University Hospital and University of Bern, Bern, Switzerland.; Divisions of Clinical Chemistry and Haematology, Labormedizinisches Zentrum Dr. Risch, Waldeggstrasse, Liebefeld b, Bern, Switzerland.; Labormedizinisches Zentrum Dr. Risch, Landstrasse, Schaan, Liechtenstein.; Central Laboratory, Kantonsspital Graubünden, Loëstrasse, 170, Chur, Switzerland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.